Patent Yard Sign in
Canadian application, no grantCanada

Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands

CA 2507980 A1 · Owner: Ianzer, Danielle · Inventors: Camargo, Antonio; Santos, Robson; Ianzer, Danielle

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is characterized by the process of preparation of pharmaceutical compositions for the development of applications of the Evasins and their structural and/or conformational analogues in chronic-degenerative diseases. It s further characterized by the process of preparation of pharmaceutical compositions and related products of the Evasins peptides and their structural and/or conformational analogues in using the cyclodextrins its derivatives, liposomes and biodegradable polymers and/or mixture of these systems.The present invention is also characterized by the identification of new biochemical and physio-pharmacological mechanisms not related to the effects on …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 9, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 9, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 9, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 9, 2003
GrantedNo grant recorded
Term endedDecember 9, 2023
Patent numberCA 2507980 A1
Classification (IPC)C07K1/00 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedDec 9, 2003Term endedDec 9, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.